Jushi Holdings (JUSHF) Interest Coverage Ratio (2021 - 2026)
Jushi Holdings' (JUSHF) quarterly Interest Coverage Ratio came in at 0.13 in Q1 2026, up 170.03% year-on-year from 0.05 in Q1 2025, and up 73.3% on a QoQ basis from 0.07 in Q4 2025.
Jushi Holdings (JUSHF) Interest Coverage Ratio (2021 - 2026) Analysis & Trends
Jushi Holdings (JUSHF) has 6 years of Interest Coverage Ratio data on file, last reported at 0.13 in Q1 2026.
- On a quarterly basis, Interest Coverage Ratio rose 170.03% year-over-year to 0.13 in Q1 2026; TTM through Mar 2026 was 0.68, a 404.53% increase from a year earlier, with the FY2025 full-year figure at 0.12, down 58.93% from the prior year.
- Interest Coverage Ratio for Q1 2026 stood at 0.13, up from 0.07 in the prior quarter.
- Over the last five years, Interest Coverage Ratio for JUSHF reached as high as 0.9 in Q2 2024 and fell as low as 5.37 in Q4 2022.
- Historically, Interest Coverage Ratio has averaged 0.65 across 5 years, with a median of 0.02 in 2024.
- Across the five-year window, Interest Coverage Ratio tumbled 1460.69% in 2022 and soared 1002.8% in 2025, its largest moves.
- Year by year, Interest Coverage Ratio stood at 5.37 in 2022, then surged by 83.1% to 0.91 in 2023, then surged by 72.02% to 0.25 in 2024, then soared by 129.44% to 0.07 in 2025, then soared by 73.3% to 0.13 in 2026.
- Per Business Quant data, the three most recent Interest Coverage Ratio figures were 0.13 in Q1 2026, 0.07 in Q4 2025, and 0.21 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 13.44 |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -2.81 |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 0.18 |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -0.07 |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 0.33 |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 5.11 |
| 10 | Jushi Holdings | 81.25 Mn | 41.54 Mn | 29.88 Mn | 0.13 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.13 |
| Dec 31, 2025 | 0.07 |
| Sep 30, 2025 | 0.21 |
| Jun 30, 2025 | 0.27 |
| Mar 31, 2025 | -0.18 |
| Dec 31, 2024 | -0.25 |
| Sep 30, 2024 | 0.02 |
| Jun 30, 2024 | 0.90 |
| Mar 31, 2024 | 0.43 |
| Dec 31, 2023 | -0.91 |
| Sep 30, 2023 | 0.30 |
| Jun 30, 2023 | 0.35 |
| Mar 31, 2023 | -0.29 |
| Dec 31, 2022 | -5.37 |
| Sep 30, 2022 | -3.79 |
| Jun 30, 2022 | -1.10 |
| Mar 31, 2022 | -1.80 |
| Dec 31, 2021 | -2.75 |
| Sep 30, 2021 | -0.24 |
| Jun 30, 2021 | -0.68 |